Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Fentanyl for Extubation Responses in Chronic Smokers
NCT04659642Phase 1Unknown
- Sponsor
- National Cancer Institute
- Start
- Nov 2020
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of dexmedetomidine and fentanyl, sponsored by National Cancer Institute. Status: unknown.
02
Drugs
dexmedetomidinefentanyl
Beyond the preview
Go deeper on NCT04659642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04659642.